Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
Phase 1
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2011-07-11
- Lead Sponsor
- Biotech Equity Partners Pty Ltd
- Target Recruit Count
- 18
- Registration Number
- NCT00625430
- Locations
- 🇦🇺
St Vincent's Hospital, Sydney, Darlinghurst, New South Wales, Australia
News
No news found